PT - JOURNAL ARTICLE AU - Yhdego, Haben H. AU - Nayebnazar, Arshia AU - Amrollahi, Fatemeh AU - Boussina, Aaron AU - Shashikumar, Supreeth AU - Wardi, Gabriel AU - Nemati, Shamim TI - Prediction of Unplanned Hospital Readmission using Clinical and Longitudinal Wearable Sensor Features AID - 10.1101/2023.04.10.23288371 DP - 2023 Jan 01 TA - medRxiv PG - 2023.04.10.23288371 4099 - http://medrxiv.org/content/early/2023/04/11/2023.04.10.23288371.short 4100 - http://medrxiv.org/content/early/2023/04/11/2023.04.10.23288371.full AB - Predictive models have been suggested as potential tools for identifying highest risk patients for hospital readmissions, in order to improve care coordination and ultimately long-term patient outcomes. However, the accuracy of current predictive models for readmission prediction is still moderate and further data enrichment is needed to identify at risk patients. This paper describes models to predict 90-day readmission, focusing on testing the predictive performance of wearable sensor features generated using multiscale entropy techniques and clinical features. Our study explores ways to incorporate pre-discharge and post-discharge wearable sensor features to make robust patient predictions. Data were used from participants enrolled in the AllofUs Research program. We extracted the inpatient cohort of patients and integrated clinical data from the electronic health records (EHR) and Fitbit sensor measurements. Entropy features were calculated from the longitudinal wearable sensor data, such as heart rate and mobility-related measurements, in order to characterize time series variability and complexity. Our best performing model acheived an AUC of 83%, and at 80% sensitivity acheived 75% specificity and 57% positive predictive value. Our results indicate that it would be possible to improve the ability to predict unplanned hospital readmissions by considering pre-discharge and post-discharge wearable features.Competing Interest StatementThe authors have declared no competing interest.Funding StatementS.N. is funded by the National Institutes of Health (R35GM143121). He is co-founder of a UCSD start-up, Healcisio Inc., which is focused on commercialization of advanced analytical decision support tools. G. W. is funded through an early career award from the National Institute of General Medical Sciences (K23GM146092).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This was a retrospective multicenter cohort study consisting of participants in the AllofUs (Registered Tired Dataset v4 CDR data dictionary [R2020Q4R3]) longitudinal study. Institutional Reviewing Board (IRB) approval was obtained prior to enrollment of patients in the AllofUs Research Program.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe AllofUs cohort is publicly available at www.allofus.nih.gov.